31 May, 2026 Author: Fortune Data Vista
The recombinant cell culture supplements market, valued at USD 964.61 million in 2025, is set to reach USD 2,626.93 million by 2033 at 12.3% CAGR — driven by CAR T-cell therapy pipelines, strategic investments by Lonza, Sartorius, and Thermo Fisher, and evolving US pharmaceutical tariff policies reshaping global bioprocessing supply chains.
17 Jan, 2026 Author: Fortune Data Vista
Brent hits $60+ as Ukraine targets Russian tankers, US blocks Venezuela; PJM capacity caps at $333/MW-day from data centers. Reuters, Utility Dive analysis on energy crisis.